Agilon Health's Price Target Decreased by 25% to $1.07/Share, Analysts' Estimates Revised Downward

Agilon Health's (AGL) average one-year price target has been revised to $1.07/share, a 25% decrease from the prior estimate of $1.43/share. The price target is an average of analysts' estimates ranging from $0.25 to $2.10/share. Institutional ownership decreased by 5.9% in the last quarter, with 383 funds reporting positions in the company. The put/call ratio of AGL is 0.03, indicating a bullish outlook.